Tandem Autologous versus Single Autologous Transplantation Followed by Allogeneic Hematopoietic Cell Transplantation for Patients with Multiple Myeloma: Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

BACKGROUND: Autologous hematopoietic cell transplantation (HCT) improves survival in patients with multiple myeloma, but disease progression remains a challenge. Allogeneic HCT (alloHCT) has the potential to reduce disease progression through graft-versus-myeloma effects. The aim of the BMT CTN 0102...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krishnan, Amrita, Pasquini, Marcelo C., Logan, Brent, Stadtmauer, Edward A., Vesole, David H., Alyea, Edwin, Antin, Joseph H., Comenzo, Raymond, Goodman, Stacey, Hari, Parameswaran, Laport, Ginna, Qazilbash, Muzaffar H., Rowley, Scott, Sahebi, Firoozeh, Somlo, George, Vogl, Dan T., Weisdorf, Daniel, Ewell, Marian, Wu, Juan, Geller, Nancy L., Horowitz, Mary M., Giralt, Sergio, Maloney, David G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3611089/
https://ncbi.nlm.nih.gov/pubmed/21962393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70243-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados